{"title":"胚胎植入前遗传学筛查","authors":"M. Beebeejaun, S. Sunkara","doi":"10.1201/9781351241694-6","DOIUrl":null,"url":null,"abstract":"In the last 30 years, genetic testing techniques have been developed to identify chromosomally normal embryos in vitro, thereby potentially increasing the proportion of successful cycles with elective single-embryo transfer, and minimizing twin-pregnancy complications and miscarriages. This testing is termed \"pre-implantation genetic screening\" (PGS), in contrast to preimplantation genetic diagnosis PGD), in which testing is performed for specific genetic defects.","PeriodicalId":314117,"journal":{"name":"Controversies in Assisted Reproduction","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preimplantation Genetic Screening\",\"authors\":\"M. Beebeejaun, S. Sunkara\",\"doi\":\"10.1201/9781351241694-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the last 30 years, genetic testing techniques have been developed to identify chromosomally normal embryos in vitro, thereby potentially increasing the proportion of successful cycles with elective single-embryo transfer, and minimizing twin-pregnancy complications and miscarriages. This testing is termed \\\"pre-implantation genetic screening\\\" (PGS), in contrast to preimplantation genetic diagnosis PGD), in which testing is performed for specific genetic defects.\",\"PeriodicalId\":314117,\"journal\":{\"name\":\"Controversies in Assisted Reproduction\",\"volume\":\"34 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Controversies in Assisted Reproduction\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1201/9781351241694-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Controversies in Assisted Reproduction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1201/9781351241694-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
In the last 30 years, genetic testing techniques have been developed to identify chromosomally normal embryos in vitro, thereby potentially increasing the proportion of successful cycles with elective single-embryo transfer, and minimizing twin-pregnancy complications and miscarriages. This testing is termed "pre-implantation genetic screening" (PGS), in contrast to preimplantation genetic diagnosis PGD), in which testing is performed for specific genetic defects.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
